Immupharma plc (IMM)

Price—Loading quote
IMMLondon Stock Exchange
Loading local price history

Financial charts

Net income

Total cash / debt

CashTotal debt

Financial statements

5 annual periodsNewest to oldest
20252024202320222021
Revenue£0£0£0£0N/A
Research & development£1.3M£1.2M£2.0M£2.0MN/A
Operating expenses£2.5M£2.3M£3.1M£3.0MN/A
Operating income−£2.5M−£2.3M−£3.1M−£3.0MN/A
Net income−£1.8M−£2.5M−£2.9M−£3.8MN/A
Basic EPSper basic shareN/A-£0.01-£0.01-£0.01-£0.03
Diluted EPSper diluted shareN/A-£0.01-£0.01-£0.01-£0.03

Owners

Reported ownership

Verified ownership data is not available for this listing yet.

Community posts

It’s quiet here.

No posts about IMM yet. Start the conversation.

Write the first post